CONGENITAL VAS DEFERENS ABSENCE

This adverse event was reported 20 times

CONGENITAL VAS DEFERENS ABSENCE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DORZOLAMIDE 13 0.0016
1 CANDESARTAN 10 0.0003
2 METOPROLOL SUCCINATE ER TABLETS 11 0.0002
3 METOPROLOL SUCCINATE 11 0.0001
4 LAMOTIRIGINE 9 0.0001
5 LAMOTRIGINE CHEWABLE DISPERSIBLE 9 0.0001
6 CANDESARTAN CILEXETIL 3 0.0001
7 ASFOTASE ALFA 1 0.0001
8 ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR 1 0.0001
9 LAMOTRIGINE 9 0.0001
See all drugs enriched for association with CONGENITAL VAS DEFERENS ABSENCE

CONGENITAL VAS DEFERENS ABSENCE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
1 Mood Stabilizer [EPC] 9 0.0000
2 Anti-epileptic Agent [EPC] 9 0.0000
3 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
4 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with CONGENITAL VAS DEFERENS ABSENCE